Systemic treatment patterns and adherence to guidelines in Japanese patients with metastatic non-small cell lung cancer
New NSCLC drug introduction increased regardless of age, suggesting prognosis improvement. More efficient drug application and broader guideline dissemination are required.
Authors
- Tsutomu Yamazaki (ORCID: https://orcid.org/0000-0001-6510-9865)
- Shunya Ikeda (ORCID: https://orcid.org/0000-0001-6180-246X)
- Koichi Ishikawa
- Kiyohide Fushimi (ORCID: https://orcid.org/0000-0002-1894-0290)
- Keiko Nishimyo
Institutions
- Shanghai Institute for Science of Science (CN)
- Institute of Science Tokyo (JP)
- International University of Health and Welfare (JP)
Publication Details
- Journal
- Future Oncology
- Published
- 2025-02-28
- DOI
- https://doi.org/10.1080/14796694.2025.2470611
- Citations
- 1
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 1.52